Progression of lung disease in preschool patients with cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 195, Issue 9, 2017, Pages 1216-1225

  Stanojevic, Sanja ^a   Davis, Stephanie D ^b   Retsch Bogart, George ^c   Webster, Hailey ^a   Davis, Miriam ^b   Johnson, Robin C ^c   Jensen, Renee ^a   Pizarro, Maria Ester ^a,d   Kane, Mica ^a   Clem, Charles C ^b   Schornick, Leah ^b   Subbarao, Padmaja ^a   Ratjen, Felix A ^a  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Cystic fibrosis; Disease progression; Lung clearance index; Lung function

Indexed keywords

ARTICLE; CHILD; CONTROLLED STUDY; COUGHING; CYSTIC FIBROSIS; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LONGITUDINAL STUDY; LUNG CLEARANCE INDEX; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RATING SCALE; SPIROMETRY; CLINICAL TRIAL; COMPLICATION; LUNG; LUNG DISEASES; LUNG FUNCTION TEST; MULTICENTER STUDY; PATHOLOGY;

CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LONGITUDINAL STUDIES; LUNG; LUNG DISEASES; MALE; RESPIRATORY FUNCTION TESTS; SPIROMETRY;

EID: 85018949572     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201610-2158OC     Document Type: Article

References (31)

1. Dakin CJ, Numa AH, Wang H, Morton J.R., Vertzyas CC, Henry RL. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 2002; 165: 904-910.
2. Khan TZ, Wagener JS, Bost T, Martinez J., Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995; 151:1075-1082.
3. Konstan MW, Hilliard KA, Norvell T.M., Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994; 150:448-454.
4. Linnane BM, Hall GL, Nolan G, Brennan S., Stick SM, Sly PD, Robertson CF, Robinson P.J., Franklin PJ, Turner SW, et al.; AREST-CF. Lung function in infants with cystic fibrosis diagnosed by newborn screening. Am J Respir Crit Care Med 2008; 178:1238-1244.
5. Ranganathan SC, Dezateux C, Bush A., Carr SB, Castle RA, Madge S, Price J., Stroobant J, Wade A, Wallis C., et al.; London Collaborative Cystic Fibrosis Group. Airway function in infants newly diagnosed with cystic fibrosis. Lancet 2001; 358:1964-1965.
6. Sly PD, Brennan S, Gangell C., de Klerk N, Murray C, Mott L., Stick SM, Robinson PJ, Robertson CF, Ranganathan SC; Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST-CF). Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med 2009; 180:146-152.
7. Davies J, Sheridan H, Bell N., Cunningham S, Davis SD, Elborn J.S., Milla CE, Starner TD, Weiner DJ, Lee P.S., et al. Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial. Lancet Respir Med 2013; 1:630-638.
8. Subbarao P, Stanojevic S, Brown M., Jensen R, Rosenfeld M, Davis S., Brumback L, Gustafsson P, Ratjen F. Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline. Am J Respir Crit Care Med 2013; 188:456-460.
9. Aurora P, Bush A, Gustafsson P., Oliver C, Wallis C, Price J., Stroobant J, Carr S, Stocks J; London Cystic Fibrosis Collaboration. Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis. Am J Respir Crit Care Med 2005; 171:249-256.
10. Kieninger E, Singer F, Fuchs O., Abbas C, Frey U, Regamey N., Casaulta C, Latzin P. Long-term course of lung clearance index between infancy and school-age in cystic fibrosis subjects. J Cyst Fibros 2011; 10:487-490.
11. Kraemer R, Blum A, Schibler A., Ammann RA, Gallati S. Ventilation inhomogeneities in relation to standard lung function in patients with cystic fibrosis. Am J Respir Crit Care Med 2005; 171:371-378.
12. Aurora P, Stanojevic S, Wade A., Oliver C, Kozlowska W, Lum S., Bush A, Price J, Carr S.B., Shankar A., et al. Lung clearance index at 4 years predicts subsequent lung function in children with cystic fibrosis. Am J Respir Crit Care Med 183:752-758.
13. Jensen R, Pizarro M, Klingel M., Stanojevic S, Webster H, McDonald N., et al. Progression and variability of LCI in preschool children with cystic fibrosis [abstract]. Pediatr Pulmonol 2015; 50(S41):191.
14. Stanojevic S, Jensen R, Webser H., Kane M, Pizarro ME, Davis S, et al Tracking pulmonary exacerbations in preschool children using the lung clearance index [abstract]. Eur Respir J 2016; 48(Suppl 60):OA1490.
15. Webster H, Pizarro M, McDonald N., Jensen R, Klingel M, Stanojevic S., et al. Utility of the lung clearance index to monitor pulmonary exacerbations in young children with cystic fibrosis [abstract]. Pediatr Pulmonol 2015; 50(S41):242.
16. Stanojevic S, Jensen R, Webster H., Subbarao P, Pittman J, Davis S.D., et al. Defining the variability of the lung clearance index in health and disease for preschool children [abstract]. Pediatr Pulmonol 2015; 50(S28):245.
17. Jensen R, Stanojevic S, Webster H., Gibney K, McDonald N, Stanojevic S., et al. Feasibility of longitudinal multiple breath washout measurements in preschool children [abstract]. Am J Respir Crit Care Med 2014; 189:A1032.
18. Webster H, Jensen R, McDonald N., Subbarao P, Stanojevic S, Ratjen F. Feasibility of longitudinal multiple breath washout measurements in preschool children [abstract]. Pediatr Pulmonol 2014; 49(S38):215.
19. Beydon N, Davis SD, Lombardi E, Allen J.L., Arets HG, Aurora P, Bisgaard H, Davis G.M., Ducharme FM, Eigen H, et al.; American Thoracic Society/European Respiratory Society Working Group on Infant and Young Children Pulmonary Function Testing. An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med 2007; 175:1304-1345.
20. VanDevanter DR, Elkin EP, Pasta D.J., Morgan WJ, Konstan MW; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Changing thresholds and incidence of antibiotic treatment of cystic fibrosis pulmonary exacerbations, 1995-2005. J Cyst Fibros 2013; 12:332-337.
21. Waters V, Stanojevic S, Atenafu E.G., Lu A., Yau Y, Tullis E, Ratjen F. Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis. Eur Respir J 2012; 40:61-66.
22. Wagener JS, Rasouliyan L, VanDevanter D.R., Pasta DJ, Regelmann WE, Morgan WJ, Konstan MW; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol 2013; 48:666-673.
23. Stanojevic S, McDonald A, Waters V., MacDonald S, Horton E, Tullis E., Ratjen F. Effect of pulmonary exacerbations treated with oral antibiotics on clinical outcomes in cystic fibrosis. Thorax [online ahead of print] 9 Sep 2016; DOI: 10.1136/thoraxjnl-2016-208450.
24. Stahl M, Wielpütz MO, Graeber S.Y., Joachim C., Sommerburg O, Kauczor HU, Puderbach M, Eichinger M., Mall MA. Comparison of lung clearance index and magnetic resonance imaging for assessment of lung disease in children with cystic fibrosis. Am J Respir Crit Care Med 2016:195;349-359.
25. Sonneveld N, Stanojevic S, Amin R., Aurora P, Davies J, Elborn J.S., Horsley A., Latzin P, O'Neill K, Robinson P, et al Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations. Eur Respir J 2015; 46:1055-1064.
26. Anstead M, Saiman L, Mayer-Hamblett N, Lands L.C., Kloster M., Goss CH, Rose L, Burns JL, Marshall B, Ratjen F. Pulmonary exacerbations in CF patients with early lung disease. J Cyst Fibros 2014; 13:74-79.
27. Simpson SJ, Ranganathan S, Park J., Turkovic L, Robins-Browne RM, Skoric B, Ramsey K.A., Rosenow T., Banton GL, Berry L, et al.; AREST CF. Progressive ventilation inhomogeneity in infants with cystic fibrosis after pulmonary infection. Eur Respir J 2015; 46:1680-1690.
28. Rosenfeld M, Bernardo-Ocampo C, Emerson J., Genatossio A, Burns J, Gibson R. Prevalence of cystic fibrosis pathogens in the oropharynx of healthy children and implications for cystic fibrosis care. J Cyst Fibros 2012; 11:456-457.
29. O'Neill K., Tunney MM, Johnston E, Rowan S., Downey DG, Rendall J, Reid A, Bradbury I., Elborn JS, Bradley JM. Lung clearance index in adults and children with cystic fibrosis. Chest 2016; 150:1323-1332.
30. Chinn S. Statistics in respiratory medicine. 2. Repeatability and method comparison. Thorax 1991; 46:454-456.
31. Jensen R, Stanojevic S, Klingel M., Pizarro ME, Hall GL, Ramsey K, Foong R., Saunders C, Robinson PD, Webster H, et al A systematic approach to multiple breath nitrogen washout test quality. PLoS One 2016; 11:e0157523.